Literature DB >> 30262956

Dysbiosis in the Gut Bacterial Microbiome of Patients with Uveitis, an Inflammatory Disease of the Eye.

Sama Kalyana Chakravarthy1, Rajagopalaboopathi Jayasudha1, Gumpili Sai Prashanthi1, Mohammed Hasnat Ali2, Savitri Sharma1, Mudit Tyagi3, Sisinthy Shivaji1.   

Abstract

Uveitis (UVT), an inflammatory disease of the eye significantly contributes to vision impairment and blindness. Uveitis is associated with systemic infectious and autoimmune diseases, but in most cases, the aetiology remains unidentified. Dysbiosis in the gut microbiome has been implicated in autoimmune diseases, inflammatory diseases, cancers and mental disorders. In a mice model of autoimmune UVT, it was observed that manipulating the gut microbiome reduces the inflammation and disease severity. Further, alterations in the bacterial gut microbiome and their metabolites were reported in UVT patients from a Chinese cohort. Hence, it is worth comparing the bacterial gut microbiome of UVT patients with that of healthy controls (HC) to ascertain whether dysbiosis of the gut microbiome has implications in UVT. Our analyses showed reduced diversity of several anti-inflammatory organisms including Faecalibacterium, Bacteroides, Lachnospira, Ruminococcus and members of Lachnospiraceae and Ruminococcaceae families, and enrichment of Prevotella (proinflammatory) and Streptococcus (pathogenic) OTUs in UVT microbiomes compared to HC. In addition, decrease in probiotic and antibacterial organisms was observed in UVT compared to HC microbiomes. Heatmap and PCoA plots also indicated significant variations in the microbiomes of UVT versus HC. This is the first study demonstrating dysbiosis in the gut bacterial communities of UVT patients in an Indian cohort and suggests a role of the gut microbiome in the pathophysiology of UVT.

Entities:  

Keywords:  Dysbiosis; Gut microbiome; Illumina Miseq; Uveitis; V3–V4 region of 16S rRNA gene

Year:  2018        PMID: 30262956      PMCID: PMC6141402          DOI: 10.1007/s12088-018-0746-9

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  39 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Gut Microbiota Composition and Fecal Metabolic Phenotype in Patients With Acute Anterior Uveitis.

Authors:  Xinyue Huang; Zi Ye; Qingfeng Cao; Guannan Su; Qingfeng Wang; Jing Deng; Chunjiang Zhou; Aize Kijlstra; Peizeng Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

3.  Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Authors:  Patrick D Schloss; Sarah L Westcott; Thomas Ryabin; Justine R Hall; Martin Hartmann; Emily B Hollister; Ryan A Lesniewski; Brian B Oakley; Donovan H Parks; Courtney J Robinson; Jason W Sahl; Blaz Stres; Gerhard G Thallinger; David J Van Horn; Carolyn F Weber
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

4.  FLASH: fast length adjustment of short reads to improve genome assemblies.

Authors:  Tanja Magoč; Steven L Salzberg
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

5.  Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.

Authors:  Carlotta De Filippo; Duccio Cavalieri; Monica Di Paola; Matteo Ramazzotti; Jean Baptiste Poullet; Sebastien Massart; Silvia Collini; Giuseppe Pieraccini; Paolo Lionetti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

6.  Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.

Authors:  Seungha Kang; Stuart E Denman; Mark Morrison; Zhongtang Yu; Joel Dore; Marion Leclerc; Chris S McSweeney
Journal:  Inflamm Bowel Dis       Date:  2010-12       Impact factor: 5.325

7.  Gut bacterial diversity of the tribes of India and comparison with the worldwide data.

Authors:  Madhusmita Dehingia; Kanchal Thangjam Devi; Narayan C Talukdar; Rupjyoti Talukdar; Nageshwar Reddy; Sharmila S Mande; Manab Deka; Mojibur R Khan
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

Review 8.  Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases.

Authors:  James L Richards; Yu Anne Yap; Keiran H McLeod; Charles R Mackay; Eliana Mariño
Journal:  Clin Transl Immunology       Date:  2016-05-13

9.  Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing.

Authors:  Xin Fang; Xin Wang; Shaoguo Yang; Fanjing Meng; Xiaolei Wang; Hua Wei; Tingtao Chen
Journal:  Front Microbiol       Date:  2016-09-20       Impact factor: 5.640

10.  Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis.

Authors:  Yukiko K Nakamura; Christina Metea; Lisa Karstens; Mark Asquith; Henry Gruner; Cathleen Moscibrocki; Iris Lee; Colin J Brislawn; Janet K Jansson; James T Rosenbaum; Phoebe Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

View more
  41 in total

1.  Intestinal microbiome: a new target for chalaziosis treatment in children?

Authors:  Mariaelena Filippelli; Roberto dell'Omo; Angela Amoruso; Ilaria Paiano; Marco Pane; Pasquale Napolitano; Silvia Bartollino; Ciro Costagliola
Journal:  Eur J Pediatr       Date:  2020-11-23       Impact factor: 3.183

Review 2.  Uveitis and the gut microbiota.

Authors:  Shilpa Kodati; H Nida Sen
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-09       Impact factor: 4.098

3.  Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye.

Authors:  Rajagopalaboopathi Jayasudha; Sama Kalyana Chakravarthy; Gumpili Sai Prashanthi; Savitri Sharma; Prashant Garg; Somasheila I Murthy; Sisinthy Shivaji
Journal:  J Biosci       Date:  2018-12       Impact factor: 1.826

4.  Tp0684, Tp0750, and Tp0792 Recombinant Proteins as Antigens for the Serodiagnosis of Syphilis.

Authors:  Júlio Henrique Ferreira de Sá Queiroz; Marcelo Dos Santos Barbosa; Lais Gonçalves Ortolani Miranda; Natasha Rodrigues de Oliveira; Odir Antônio Dellagostin; Silvana Beutinger Marchioro; Simone Simionatto
Journal:  Indian J Microbiol       Date:  2022-04-19

5.  2'-Fucosyllactose Increases the Abundance of Blautia in the Presence of Extracellular Fucosidase-Possessing Bacteria.

Authors:  Ayako Horigome; Nanami Hashikura; Keisuke Yoshida; Jin-Zhong Xiao; Toshitaka Odamaki
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

Review 6.  Microbiome in Immune-Mediated Uveitis.

Authors:  Carmen Antía Rodríguez-Fernández; Manuel Busto Iglesias; Begoña de Domingo; Kelly Conde-Pérez; Juan A Vallejo; Lorena Rodríguez-Martínez; Miguel González-Barcia; Victor Llorenç; Cristina Mondelo-Garcia; Margarita Poza; Anxo Fernández-Ferreiro
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 7.  Connect between gut microbiome and diseases of the human eye.

Authors:  S Shivaji
Journal:  J Biosci       Date:  2019-10       Impact factor: 1.826

8.  A Comprehensive Assessment of the Safety of Blautia producta DSM 2950.

Authors:  Xuemei Liu; Weiling Guo; Shumao Cui; Xin Tang; Jianxin Zhao; Hao Zhang; Bingyong Mao; Wei Chen
Journal:  Microorganisms       Date:  2021-04-23

9.  Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion.

Authors:  Mariaelena Filippelli; Roberto dell'Omo; Angela Amoruso; Ilaria Paiano; Marco Pane; Pasquale Napolitano; Giuseppe Campagna; Silvia Bartollino; Ciro Costagliola
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

Review 10.  A Role for Folate in Microbiome-Linked Control of Autoimmunity.

Authors:  Christine Mölzer; Heather M Wilson; Lucia Kuffova; John V Forrester
Journal:  J Immunol Res       Date:  2021-05-19       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.